Daxor Corporation (NASDAQ: DXR) Stock Information | RedChip

Daxor Corporation (NASDAQ: DXR)


$9.02
-0.1800 ( -1.96% ) 0.2K

Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.

Market Data


Open


$9.02

Previous close


$9.20

Volume


0.2K

Market cap


$44.50M

Day range


$8.91 - $9.31

52 week range


$7.11 - $10.15

SEC Fillings


Form Type Description Pages Date
nt-ncsr/a Quarterly Reports 1 Feb 29, 2024
nt-ncsr Quarterly Reports 1 Feb 29, 2024
8-k 8K-related 14 Jan 02, 2024
4 Insider transactions 1 Dec 06, 2023
4 Insider transactions 1 Dec 01, 2023
4 Insider transactions 1 Dec 01, 2023
8-k 8K-related 13 Nov 28, 2023
4 Insider transactions 1 Nov 27, 2023
4 Insider transactions 1 Nov 24, 2023
nport-p Other 1 Nov 24, 2023

Latest News